AAV-based gene therapy
Total Trials
1
As Lead Sponsor
As Collaborator
0
NCT06721611
A Comprehensive Optical Blood Pressure Assessment Tool to Identify Cases of Unscreened Hypertension Across an Active Population in the U.S.
Phase: N/A
Role: Lead Sponsor
Start: Jan 16, 2025
Completion: Aug 31, 2025
Loading map...